Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06UJA
|
||||
| Former ID |
DIB020387
|
||||
| Drug Name |
MNI-136
|
||||
| Synonyms |
MNI 136
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [541390] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H16BrN3O
|
||||
| InChI |
InChI=1S/C21H16BrN3O/c22-17-4-5-19-20(13-17)24-18(6-7-21(26)25-19)16-3-1-2-15(12-16)14-8-10-23-11-9-14/h1-5,8-13H,6-7H2,(H,25,26)/b24-18+
|
||||
| InChIKey |
BLAQAVITPVXJJS-HKOYGPOVSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Metabotropic glutamate receptor 2 | Target Info | Modulator (allosteric modulator) | [528775] | |
| Metabotropic glutamate receptor3 | Target Info | Modulator (allosteric modulator) | [528775] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Ionotropic glutamate receptor pathway | |||||
| Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Metabotropic glutamate receptor group II pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.